Kyowa Kirin & Amgen collaborate to research importance of the OX40 molecule in atopic dermatitis

Amgen's collaboration with Kyowa Kirin has been a four decade-long commitment to providing patients and healthcare providers with the care and support they need. As our teamwork continues, we’re dedicating our efforts to researching care options for people living with moderate to severe atopic dermatitis.

Hear from Amgen’s VP of Global Medical Ponda Motsepe-Ditshego and Kyowa Kirin’s VP of Medical Affairs Fiona Herr, PhD on the complexities of atopic dermatitis.



Recruitment
Fraud Alert

Contact Us

*Required

Contact Form

  • For questions related to our products, please use the links provided under Our Medicines.

By clicking the Send button, you authorize Kyowa Kirin, Inc., its affiliates, subsidiaries, and third-party agents to contact you by mail and/or email to provide information on products, programs, services, and disease-state information and/or utilize your information for market research or analytics. Kyowa Kirin, Inc., its affiliates, subsidiaries, and third-party agents will not utilize or distribute your personal information outside the above terms of consent.

Are you visiting this site from Canada? If so, consider visiting our Canadian site. It's designed to bring you up-to-date content.

 

Click "Leave Page" to visit the Kyowa Kirin Canada site.

Or click “OK” to stay on the Kyowa Kirin US site.

Option to close the window